Skip to Content

New Drugs, New Targets – Highlights from ASH22

Stephanie Lee, MD, MPH, of Fred Hutchinson Cancer Center and former president of ASH shares the key messages from a range of studies presented at the Press Briefing focused on novel therapeutic approaches and new treatment paradigms for several hematologic diseases. They all represent great expectations for better treatments and even cures, especially for patients who are heavily pre-treated and do not have a lot of other treatment options.

Stephanie J. Lee

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top